Compare Novartis AG (NVS) vs Southern Company (SO) Price & Performance

Novartis AGTrade

Southern CompanyTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Southern Company — how do they compare? Novartis AG trades at $138.17 (market cap $262.64B), while Southern Company trades at $88.39 (market cap $102.37B). The key difference: Novartis AG is far larger — about 2.6× Southern Company's market cap, and Novartis AG pays the higher dividend (3.44%). Which is the better fit depends on your goals.

	NVS	SO
Market Cap	$262.64B	$102.37B
Sector	Health	Utilities
52-Week High	$168.62	$99.72
52-Week Low	$121.80	$84.08
Enterprise Value	$303.97B	$176.47B
Dividend Yield	3.44%	3.42%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Novartis AG

Novartis (NVS) is trading at $137.70, down 13.93% following significant clinical trial setbacks for del-desiran and pelacarsen. The stock shows bearish technical signals with support at $133-$136 and resistance at $140-$143. Fundamentally, the company maintains strong profitability with 74.74% gross margins and 22.5% net income margins, though recent pipeline failures have overshadowed solid financial performance.

While Novartis maintains strong financial fundamentals and reiterated 2025-2030 growth guidance, the recent clinical trial failures create near-term uncertainty. The stock faces pressure from pipeline setbacks but offers value at current levels for long-term investors willing to weather development risks. Analyst consensus remains cautious with 68% hold ratings.

Southern Company

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVS

Novartis shares plunge 12.5% after two Phase 3 drug trials fail primary goalsPRNewsWire · 16 hours agoBearish Amgen shares drop 10% after Novartis fails cholesterol drug trial, despite Amgen's own cancer trial success.24/7 Wall Street · 1 day agoBearish Novartis shares drop 10% after del-desiran fails Phase 3 trial for myotonic dystrophyProactive Investors · 1 day agoBearish View details →

PowerSecure to provide backup power solution for Keel Infrastructure's Moses Lake data center expansionPRNewsWire · 19 hours agoBullish View details →

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

About Southern Company

Southern Company is a U.S. energy company with electric and gas utility businesses. Its power generation portfolio includes natural gas, nuclear, renewable, and other energy sources.